Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis

Oncologist. 2012;17(3):312-20. doi: 10.1634/theoncologist.2011-0315. Epub 2012 Mar 1.

Abstract

Recent studies implicate single nucleotide polymorphisms (SNPs) within the 8q24 region as a risk factor for prostate cancer (PCa). New developments suggest that 8q24 encodes regulators of the nearby MYC gene, a known oncogene. In order to better understand the implications of SNPs in this region, we performed meta-analyses, stratified by race, of seven SNPs and one microsatellite marker previously identified as risk loci on the 8q24 region of the genome. In addition, we reviewed the literature examining the possible associations between these polymorphisms and clinicopathological features of PCa. The results of the meta-analyses indicate that rs6983267, rs1447295, rs6983561, rs7837688, rs16901979, and DG8S737 are significantly associated with a higher risk for PCa for at least one race, whereas the variants rs13254738 and rs7000448 are not. The degree of association and frequency of the causative allele varied among men of different races. Though several studies have demonstrated an association between certain 8q24 SNPs and clinicopathological features of the disease, review of this topic revealed conflicting results.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Chromosomes, Human, Pair 8 / genetics
  • Gene Frequency
  • Genes, myc*
  • Genetic Association Studies
  • Humans
  • Male
  • Neoplasm Grading
  • Neoplasm Staging
  • Polymorphism, Single Nucleotide / genetics*
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / epidemiology*
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / pathology
  • Racial Groups / genetics*
  • Risk Factors

Substances

  • Prostate-Specific Antigen